Pharmicell CEO Kim Hyunsoo Purchases Company Shares with Entire Dividend, Demonstrates Commitment to Enhancing Corporate Value

Pharmicell announced on April 29 that CEO Kim Hyunsoo used 100 million won in cash dividends received this year to purchase 10,300 shares of the company’s own stock. This decision, made simultaneously with the company’s first-ever cash dividend since its founding, is seen as a reflection of management’s strong commitment to increasing corporate value and returning profits to shareholders.

Pharmicell achieved record-high results last year, driven by the rapid growth of the artificial intelligence (AI) industry. Based on this performance, the company decided to issue its first cash dividend at last month’s regular general shareholders’ meeting. In addition, to respond to the large-scale increase in demand for advanced AI industrial materials and pharmaceutical raw materials, Pharmicell decided to make a new investment totaling 30 billion won to establish its third plant in Ulsan.

A Pharmicell representative stated, “The stock purchase made concurrently with the cash dividend demonstrates CEO Kim Hyunsoo’s confidence in the company’s future value,” adding, “It also clearly expresses management’s firm determination to raise the undervalued corporate value through responsible management.” The representative continued, “We expect this to have a positive effect on enhancing corporate credibility, driving company growth, and increasing shareholder value going forward.”